Skip to main content
رجوع
CI logo

Cigna Corporation

جودة البيانات: 100%
CI
NYSE Healthcare Medical - Healthcare Plans
KWD 270.36
▲ KWD 4.49 (1.69%)
القيمة السوقية: 72.22B
نطاق اليوم
KWD 264.76 KWD 270.88
نطاق 52 أسبوعًا
KWD 239.51 KWD 350.00
حجم التداول
1,398,026
متوسط 50 يوم / 200 يوم
KWD 277.87 / KWD 287.97
الإغلاق السابق
KWD 265.87

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 12.1 0.3
P/B 1.7 3.0
ROE % 14.4 3.7
Net Margin % 2.2 3.8
Rev Growth 5Y % 12.1 10.0
D/E 0.8 0.2

السعر المستهدف للمحللين

Hold
KWD 325.83 +20.5%
Low: KWD 300.00 High: KWD 375.00
مكرر الربحية المستقبلي
8.92
ربحية السهم المستقبلية
KWD 30.32
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
284.86B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 45.90
KWD 43.96 – KWD 48.40
389.85B 5
FY2029 KWD 41.01
KWD 39.27 – KWD 43.24
352.72B 2
FY2028 KWD 37.09
KWD 32.04 – KWD 41.58
319.81B 7

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-05 KWD 7.88 KWD 8.08 +2.5%
2025-10-30 KWD 7.64 KWD 7.83 +2.5%
2025-07-31 KWD 7.16 KWD 7.20 +0.6%
2025-05-02 KWD 6.35 KWD 6.74 +6.1%
2025-01-30 KWD 7.84 KWD 6.64 -15.3%
2024-10-31 KWD 7.23 KWD 7.51 +3.9%
2024-08-01 KWD 6.41 KWD 6.72 +4.8%
2024-05-02 KWD 6.22 KWD 6.47 +4.0%

Dividend History

6 yr streak

Yield

0.02%

Payout Ratio

0.27%

Growth (3Y)

10.47%

Growth (5Y)

172.77%

Ex-Date Payment Date Amount Yield
Mar 05, 2026 Mar 19, 2026 KWD 1.56 2.17%
Dec 04, 2025 Dec 18, 2025 KWD 1.51 2.25%
Sep 04, 2025 Sep 18, 2025 KWD 1.51 1.95%
Jun 03, 2025 Jun 18, 2025 KWD 1.51 1.87%
Mar 05, 2025 Mar 20, 2025 KWD 1.51 1.84%
Dec 04, 2024 Dec 19, 2024 KWD 1.40 1.70%
Sep 04, 2024 Sep 19, 2024 KWD 1.40 1.48%
Jun 04, 2024 Jun 20, 2024 KWD 1.40 1.56%
Mar 05, 2024 Mar 21, 2024 KWD 1.40 1.53%
Dec 05, 2023 Dec 21, 2023 KWD 1.23 1.91%
Sep 05, 2023 Sep 21, 2023 KWD 1.23 1.73%
Jun 06, 2023 Jun 22, 2023 KWD 1.23 1.79%
Mar 07, 2023 Mar 23, 2023 KWD 1.23 1.63%
Dec 05, 2022 Dec 21, 2022 KWD 1.12 1.37%
Sep 06, 2022 Sep 22, 2022 KWD 1.12 1.53%
Jun 07, 2022 Jun 23, 2022 KWD 1.12 1.62%
Mar 08, 2022 Mar 24, 2022 KWD 1.12 1.80%
Dec 06, 2021 Dec 22, 2021 KWD 1.00 1.94%
Sep 07, 2021 Sep 23, 2021 KWD 1.00 1.39%
Jun 07, 2021 Jun 23, 2021 KWD 1.00 0.81%

النقاط الرئيسية

Revenue grew 12.11% annually over 5 years — strong growth
Earnings grew 73.47% over the past year
ROE of 14.40% — decent returns on equity
Generating 8.39B in free cash flow
P/E of 12.12 — trading at a low valuation
PEG of 0.15 suggests growth is underpriced

النمو

Revenue Growth (5Y)
12.11%
Revenue (1Y)11.26%
Earnings (1Y)73.47%
FCF Growth (3Y)-9.49%

الجودة

Return on Equity
14.40%
ROIC9.36%
Net Margin2.17%
Op. Margin3.32%

الأمان

Debt / Equity
0.75
Current Ratio0.85
Interest Coverage6.61

التقييم

P/E Ratio
12.12
Forward P/E8.92
P/B Ratio1.73
EV/EBITDA10.52
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 11.26% Revenue Growth (3Y) 18.66%
Earnings Growth (1Y) 73.47% Earnings Growth (3Y) 7.40%
Revenue Growth (5Y) 12.11% Earnings Growth (5Y) 2.63%
Profitability
Revenue (TTM) 274.95B Net Income (TTM) 5.96B
ROE 14.40% ROA 3.77%
Gross Margin 9.45% Operating Margin 3.32%
Net Margin 2.17% Free Cash Flow (TTM) 8.39B
ROIC 9.36% FCF Growth (3Y) -9.49%
Safety
Debt / Equity 0.75 Current Ratio 0.85
Interest Coverage 6.61
Dividends
Dividend Yield 0.02% Payout Ratio 0.27%
Dividend Growth (3Y) 10.47% Dividend Growth (5Y) 172.77%
Consecutive Div Years 6 yrs
Valuation
P/E Ratio 12.12 Forward P/E 8.92
P/B Ratio 1.73 P/S Ratio 0.26
PEG Ratio 0.15 Forward PEG N/A
EV/EBITDA 10.52 Fwd EV/EBITDA 6.50
Forward P/S 0.25 Fwd Earnings Yield 11.21%
FCF Yield 11.62%
Market Cap 72.22B Enterprise Value 96.01B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 274.95B 247.12B 195.27B 180.52B 174.07B
Net Income 5.96B 3.43B 5.16B 6.70B 5.37B
EPS (Diluted) 22.17 12.12 17.39 21.41 15.75
Gross Profit 25.99B 25.96B 25.18B 23.50B 22.95B
Operating Income 9.13B 9.42B 8.54B 8.45B 7.94B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 157.92B 155.88B 152.76B 143.89B 154.89B
Total Liabilities 116.05B 114.64B 106.41B 98.98B 107.71B
Shareholders' Equity 41.71B 41.03B 46.22B 44.87B 47.11B
Total Debt 31.46B 31.97B 30.93B 31.55B 34.27B
Cash & Equivalents 7.68B 7.55B 7.82B 5.92B 5.08B
Current Assets 47.81B 48.87B 37.35B 30.12B 36.13B
Current Liabilities 56.34B 57.98B 48.72B 41.23B 43.57B

درجات الاستراتيجيات

This stock passed the criteria for 3 strategies

Score = fit strength (0–100)
Rank = position among all matches
#92 of 1052
72
#273 of 618
39
#152 of 332
53

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026
دخل Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
دخل Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026